CSS
TMCI icon

Cubist Systematic Strategies’s Treace Medical Concepts TMCI Stock Holding History

Cubist Systematic Strategies’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-223,176
Closed -$1.66M – 3530
2024
Q4 		$1.66M Sell
223,176
-88,914
-28% -$595K 0.01% 1484
2024
Q3 		$1.81M Buy
+312,090
New +$2M 0.01% 1481
2024
Q2 		– Sell
-255,997
Closed -$3.34M – 4005
2024
Q1 		$3.34M Buy
+255,997
New +$3.41M 0.02% 1249
2023
Q3 		– Sell
-42,744
Closed -$1.09M – 3910
2023
Q2 		$1.09M Sell
42,744
-59,877
-58% -$1.55M 0.01% 1900
2023
Q1 		$2.59M Buy
102,621
+59,328
+137% +$1.39M 0.02% 1458
2022
Q4 		$995K Buy
43,293
+2,711
+7% +$62.4K 0.01% 2456
2022
Q3 		$896K Buy
40,582
+39,981
+6,652% +$773K 0.01% 2711
2022
Q2 		$9K Sell
601
-2,077
-78% -$35K ﹤0.01% 4278
2022
Q1 		$51K Sell
2,678
-10,708
-80% -$208K ﹤0.01% 3372
2021
Q4 		$250K Buy
+13,386
New +$276K ﹤0.01% 2918
2021
Q3 		– Sell
-12,938
Closed -$404K – 3176
2021
Q2 		$404K Buy
+12,938
New +$412K ﹤0.01% 2139

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's TMCI Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 223,176 shares — an estimated $1.66M sold.

Cubist Systematic Strategies first reported a position in TMCI in Q2 2021 and held it in 11 quarters. The position peaked at $3.34M in Q1 2024. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 223,176 Treace Medical Concepts shares in Q1 2025, an estimated $1.66M.
  • Cubist Systematic Strategies first reported a position in Treace Medical Concepts in Q2 2021 and held it in 11 quarters.
  • Cubist Systematic Strategies's Treace Medical Concepts position peaked at $3.34M in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.